Decreased α-Catenin expression is associated with poor prognosis in ESCC [70] and it has an even greater association with aggressive phenotypes and lymph node metastasis than E-Cadherin [71]. This evidence concerns the gene CDH1 and esophageal squamous cell carcinoma.